DRKS00000556已完成不适用
ADVATE / ADYNOVI Hemophilia A Outcome Database - AHEAD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 406
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Subject has moderate or severe hemophilia A (baseline factor VIII < 5%) and is being treated with ADVATE or ADYNOVI on any treatment regimen recommended by his/her treating physician. Subject, parent(s) or legally authorized representative has provided written informed consent. For ADYNOVI: Subject aged = 12 years
排除标准
- •Subject has known hypersensitivity to the active substance or to any of the excipients. Subject has a known allergic reaction to mouse or hamster proteins.
研究者
相似试验
已完成
不适用
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)Hemophilia ANCT02078427Baxalta now part of Shire951
招募中
不适用
German Pediatric Hemophilia Research DatabaseHemophilia A/BD66D67Hereditary factor VIII deficiencyHereditary factor IX deficiencyDRKS00011101Dr. v. Haunersches KinderspitalKlinikum der Universität München1,000
尚未招募
不适用
Obtain Real World Insights of Acquired Hemophilia A Patients in Japan2Acquired Hemophilia AJPRN-UMIN000047206Chugai Pharmaceutical Co., Ltd.200
已完成
不适用
Response to DDAVP In mild Hemophilia A patients, in Search for dEterminantsbleeding disorderhemophilia A10064477NL-OMON43824Academisch Medisch Centrum281
尚未招募
不适用
An observational study about the clinical profile of Hemophagocytic Lymphohistiocytosis(a disease in which own immune cells eat up blood cells resulting in fall of blood cells) in children less than 12 years and about markers that decide good and bad prognosis of the disease.CTRI/2021/03/032323one